Data gathered: November 8
Alternative Data for Ardelyx
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 38 | Sign up | Sign up | Sign up |
| Sentiment | 98 | Sign up | Sign up | Sign up |
| Webpage traffic | 11,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | 22 | Sign up | Sign up | Sign up |
| Patents | 33 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 19 | Sign up | Sign up | Sign up |
| Facebook Followers | 221 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 40 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 18,283 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,772 | Sign up | Sign up | Sign up |
| Twitter Mentions | 17 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 53 | Sign up | Sign up | Sign up |
| Linkedin Employees | 364 | Sign up | Sign up | Sign up |
About Ardelyx
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally.
| Price | $5.00 |
| Target Price | Sign up |
| Volume | 8,170,000 |
| Market Cap | $1.54B |
| Year Range | $4.94 - $9.59 |
| Dividend Yield | 0% |
| Analyst Rating | 86% buy |
| Industry | Biotechnology |
In the news
 |
Leerink Partnrs Reduces Earnings Estimates for ArdelyxNovember 6 - ETF Daily News |
|
Ardelyx (NASDAQ:ARDX) Given New $10.00 Price Target at CitigroupNovember 5 - ETF Daily News |
Ardelyx to Participate at the 2024 Jefferies London Healthcare ConferenceNovember 5 - GlobeNewswire |
|
|
Wedbush Research Analysts Cut Earnings Estimates for ArdelyxNovember 4 - ETF Daily News |
 |
Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023)November 1 - Yahoo |
 |
Q3 2024 Ardelyx Inc Earnings CallNovember 1 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 98M | 81M | 18M | -810,000 | 2.2M | -0.003 |
| Q2 '24 | 73M | 74M | -870,000 | -16M | -13M | -0.070 |
| Q1 '24 | 44M | 60M | -16M | -27M | -24M | -0.110 |
| Q4 '23 | 33M | 54M | -20M | -29M | -26M | -0.120 |
| Q3 '23 | 55M | 41M | 14M | 6.6M | 8.9M | 0.030 |
Insider Transactions View All
| RAAB MICHAEL filed to sell 1,210,108 shares at $5.9. October 31 '24 |
| RAAB MICHAEL filed to sell 1,210,108 shares at $6. October 15 '24 |
| Rosenbaum David P. filed to sell 301,946 shares at $6.9. October 1 '24 |
| RAAB MICHAEL filed to sell 1,217,608 shares at $6.1. September 27 '24 |
| Rosenbaum David P. filed to sell 153,616 shares at $6.3. September 16 '24 |
Similar companies
Read more about Ardelyx (ARDX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Ardelyx?
The Market Cap of Ardelyx is $1.54B.
What is the current stock price of Ardelyx?
Currently, the price of one share of Ardelyx stock is $5.00.
How can I analyze the ARDX stock price chart for investment decisions?
The ARDX stock price chart above provides a comprehensive visual representation of Ardelyx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ardelyx shares. Our platform offers an up-to-date ARDX stock price chart, along with technical data analysis and alternative data insights.
Does ARDX offer dividends to its shareholders?
As of our latest update, Ardelyx (ARDX) does not offer dividends to its shareholders. Investors interested in Ardelyx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ardelyx?
Some of the similar stocks of Ardelyx are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.